Pioglitazone (Actos)

DRUG3 trials

Sponsors

Texas Tech University Health Sciences Center, Brooke Army Medical Center

Conditions

Chronic Hepatitis CHepatitis cType 2 Diabetes Mellitus

Phase 1

Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus

WithdrawnNCT00232362

Texas Tech University Health Sciences CenterType 2 Diabetes Mellitus

Start: 2007-06-30End: 2008-06-30Updated: 2015-04-13

Phase 4

Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba

CompletedNCT00926614

Brooke Army Medical CenterHepatitis c

Start: 2008-09-30End: 2011-12-31Updated: 2012-02-14

Unknown Phase

Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects

CompletedNCT00926016

Brooke Army Medical CenterChronic Hepatitis C

Start: 2006-06-30End: 2010-09-30Updated: 2012-02-14